1. Home
  2. FXHO vs CLNN Comparison

FXHO vs CLNN Comparison

Compare FXHO & CLNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

FXHO

UTime Limited Class A Ordinary Shares

N/A

Current Price

$12.04

Market Cap

83.2M

Sector

N/A

ML Signal

N/A

Logo Clene Inc.

CLNN

Clene Inc.

HOLD

Current Price

$5.39

Market Cap

79.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FXHO
CLNN
Founded
N/A
2012
Country
China
United States
Employees
172
79
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
83.2M
79.1M
IPO Year
2021
N/A

Fundamental Metrics

Financial Performance
Metric
FXHO
CLNN
Price
$12.04
$5.39
Analyst Decision
Strong Buy
Analyst Count
0
4
Target Price
N/A
$33.75
AVG Volume (30 Days)
438.9K
57.4K
Earning Date
N/A
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$17.64
Revenue Next Year
N/A
$19,516.77
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$10.75
$3.25
52 Week High
$25.00
$13.50

Technical Indicators

Market Signals
Indicator
FXHO
CLNN
Relative Strength Index (RSI) 38.21 36.88
Support Level $10.75 $4.48
Resistance Level $21.10 $6.61
Average True Range (ATR) 3.64 0.34
MACD -0.53 -0.07
Stochastic Oscillator 11.20 6.05

Price Performance

Historical Comparison
FXHO
CLNN

About FXHO UTime Limited Class A Ordinary Shares

UTime Ltd is engaged in the design, development, production, sales and brand operation of mobile phones, accessories and related consumer electronics. It also provides Electronics Manufacturing Services (EMS), including Original Equipment Manufacturer (OEM) and Original Design Manufacturer (ODM) services, for renowned brands. The company operates in China and its products are sold globally, including Mexico, Brazil, the United States, and other emerging markets in South Asia and Africa as well as Europe. It has two in-house brands, UTime, known as its middle-to-high end label and targets middle class consumers from emerging markets; as its low- to mid-end brand, is positioned to the grassroots consumers and price-sensitive consumers in emerging markets.

About CLNN Clene Inc.

Clene Inc is a clinical-stage pharmaceutical company pioneering the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. It is focused on the development of therapeutics for neurodegenerative diseases. It developed an electro-crystal-chemistry drug development platform that enables the production of concentrated, stable, clean-surfaced nanocrystal suspensions. It operates in one segment the development and commercialization of dietary supplements (Supplements). Products includes CNM-Au8, CNM-ZnA, CNM-AgZn17, rMetx, KHC46.

Share on Social Networks: